How Gut Bacteria Decide Whether Cancer Immunotherapy Works
A comprehensive review details how specific gut microbes and their metabolites shape responses to cancer immunotherapy and chemotherapy, and how ...
A comprehensive review details how specific gut microbes and their metabolites shape responses to cancer immunotherapy and chemotherapy, and how ...
A new dual-branch deep learning framework called CrossBranch improves the estimation of cell-type composition from bulk, proteomic, and spatial omics ...
A new review outlines how combining PARP inhibitors with immune checkpoint inhibitors can convert immunologically cold ovarian tumors into hot ...
Memorial Sloan Kettering scientists engineered fucoidan-coated nanoparticles that selectively eliminate senescent, P-selectin-positive macrophages driving fibrosis, dissolving scar barriers around tumors ...
A comprehensive new review in Medical Oncology maps how natural killer cell therapies, from cytokine-expanded infusions to CAR-NK cells and ...
A stage-spanning single-cell atlas of bladder cancer identifies a CXCR4-positive vascular-immune barrier at the T1 stage that excludes T cells ...
A new review in Molecular Cancer details how the abundant RNA mark m6A drives cancer growth, immune evasion and treatment ...
A new review in Cancer Cell International explains how metabolic reprogramming in colorectal cancer tumors suppresses anti-tumor immunity and how ...
A bacterial protein called LukS-PV reprograms immunosuppressive macrophages in liver cancer by targeting the human C5aR1 receptor, restoring CD8-positive T-cell ...
A Dutch study finds that melanoma brain metastases harbor far fewer but more tightly clustered immune cells than other metastases, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine